NS
JNJ icon

Newman & Schimel’s Johnson & Johnson JNJ Stock Holding History

Newman & Schimel’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,175
Closed -$358K – 48
2021
Q2 		$358K Hold
2,175
– – 0.23% 38
2021
Q1 		$357K Buy
+2,175
New +$352K 0.24% 37

Other funds holding JNJ

WA
WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Newman & Schimel's JNJ Position: Q3 2021 in Review

Newman & Schimel sold out of Johnson & Johnson (JNJ) in Q3 2021, closing a stake of 2,175 shares — an estimated $358K sold.

Newman & Schimel first reported a position in JNJ in Q1 2021 and held it in 2 quarters. The position peaked at $358K in Q2 2021. 3,312 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • Newman & Schimel reported no remaining Johnson & Johnson position as of Q3 2021 after selling out during the quarter.
  • Newman & Schimel sold 2,175 Johnson & Johnson shares in Q3 2021, an estimated $358K.
  • Newman & Schimel first reported a position in Johnson & Johnson in Q1 2021 and held it in 2 quarters.
  • Newman & Schimel's Johnson & Johnson position peaked at $358K in Q2 2021.
  • 3,312 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on Newman & Schimel's 13F filing for Q3 2021, filed 7 Oct 2021.